Pictured: Abstract visualization of human brain/iStock, bawanch
An FDA advisory committee on Monday unanimously voted for the approval of Eli Lilly’s anti-amyloid antibody donanemab, concluding that the benefits outweighed the risk for Alzheimer’s disease patients. At the same time, thousands…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Generative AI Finds Its Footing in Drug Development
Pictured: Robot hand holding microscope, pill bottles and DNA/Taylor Tieden for BioSpace Xaira Therapeutics launched April 23 with $1 billion behind it to apply artificial intelligence to drug discovery and development. It was the largest […]
How Utah’s AI prescribing experiment is going so far
Utah has released early data from a closely watched program that tests using AI to renew prescriptions for patients with chronic conditions. Since mid-December, Doctronic has been automating prescription renewals for nearly … Click here […]
Level Education Group Acquires CEU Creations
Acquisition of Livestream Training Company Designed to Complement CE4Less Read-Only Offerings SOUTH JORDAN, Utah, Feb. 27, 2024 /PRNewswire-PRWeb/ — Level Education Group, parent company of CE4Less, NurseCE4Less, and CCM4Less, which provides online continuing education (CE) […]
